Division of Vascular Surgery and Endovascular Surgery, Baylor College of Medicine, Baylor-St. Luke's Hospital, Houston, Texas.
Published: January 2022
AI Article Synopsis
Article Abstract
Endograft infection with Listeria monocytogenes is a rare, potentially devastating complication of endovascular aortic aneurysm repair. To our knowledge, only 8 cases have been reported. We describe the case of a 72-year-old man who presented with L. monocytogenes endograft infection and a 19-cm degenerative aneurysm 9 years after having undergone endovascular repair of an abdominal aortic aneurysm. The infection was successfully treated with open surgical excision of the infected aortoiliac endograft and its replacement with a rifampin-soaked, bifurcated Dacron graft.
Introduction: We present a case of late endograft infection that progressed to the left iliac and femoral arteries, leading to left lower extremity gangrene, and the patient's death.
Case: A 65-year-old male with a history of endovascular abdominal aortic aneurysm repair (EVAR) developed left acute limb ischemia (Rutherford category III) and abdominal pain. A CT scan showed significant gas formation around the endograft and complete occlusion of the left distal iliac artery to the femoral arteries.
Aortic injuries related to unstable spinal fractures, although rare, can be life-threatening and require quick, collaborative medical responses to avoid serious complications.
A case study of a woman with a spinal fracture after a road accident highlighted the potential dangers of surgery without an aortic prosthesis, which could lead to severe bleeding, while using a prosthesis carries risks of mini-strokes and other complications.
The treatment approach involved using a thoracic prosthesis prior to spinal surgery, emphasizing the need for careful planning and consideration of the patient's unique anatomy to minimize risks of aortic injury during the surgical process.
This review evaluated the effectiveness and safety of bifurcated endografts for treating aortoiliac disease (AOID) by analyzing multiple studies across various databases.*
-
Ten studies involving 365 patients primarily used the AFX endograft, showing high primary patency rates at 12, 24, and 36 months, with estimates around 90-94% and low rates of major complications.*
-
While the initial findings suggest that bifurcated endografts are a promising option for AOID treatment, further research is needed to conclusively determine their long-term efficacy and safety.*
Introduction: Some patients with an infective native aortic aneurysm (INAA) develop an aortic vascular graft or endograft infection (VGEI) even after successful open surgical repair or endovascular intervention. The aim of the systematic review and meta-analysis performed herein was to compare the clinical outcomes of different surgical and antibiotic treatment strategies.
Methods: We systematically searched PubMed, MEDLINE, EMBASE and Web of Science.
